(Q37337682)

19 August 2017

1 reference

title

Comorbid psychiatric and substance abuse disorders: recent treatment research (English)

1 reference

19 August 2017

0 references

1 reference

2

Frances Levin

1 reference

19 August 2017

Paula Riggs

1

1 reference

19 August 2017

Alan I Green

series ordinal

3

1 reference

19 August 2017

Frank Vocci

series ordinal

4

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

29

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

51-63

1 reference

Development of psychiatric comorbidity with substance abuse in adolescents: effects of timing and sex.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Long-term stability of Child Behavior Checklist profile types in a child psychiatric clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Adolescent substance abuse: a review of the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Pharmacotherapy of adolescent substance use disorders: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Substance use problems and associated psychiatric symptoms among adolescents in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Etiology of adolescent substance abuse: a developmental perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Drug treatment outcomes for adolescents with comorbid mental and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

An overview of controlled studies of adolescent substance abuse treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Psychosocial treatments for ADHD in teens and adults: a practice-friendly review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Dual diagnosis and successful participation of adolescents in substance abuse treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

New developments in psychopharmacology of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Gender and comorbid psychopathology in adolescents with alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Treatment strategies for co-occurring ADHD and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Substance abuse and schizophrenia: pharmacotherapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Dysfunction of ventral striatal reward prediction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Clozapine reduces alcohol drinking in Syrian golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Thirty-month relapse trajectory cluster groups among adolescents discharged from out-patient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897070802218794

10.1080/08897070802218794

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference